What You Should Know:
– Reimagine Care the nation’s leading provider of on-demand cancer care, and Memorial Hermann Health System one of the largest not-for-profit health systems in Texas, are excited to announce a multi-year expansion of…
Continue Reading
Introduction
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, primarily due to the challenges in early detection and monitoring. However, the recent advancements in artificial intelligence (AI) are revolutionizing lung cancer…
What You Should Know:
– Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.
– The new AI solution is now…
Continue Reading
Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical
The landscape of cancer treatment has continued to evolve, and the annual ASCO Meetings often set the stage for “what’s next in cancer care.” The…
Continue Reading
What You Should Know:
– Alfred Health, a Victorian healthcare network, has expanded its partnership with Oracle Health by implementing the Oracle Oncology EHR solution. This move marks a significant step forward in providing comprehensive…
Continue Reading
What You Should Know:
– Avenda Health, a pioneer in AI-powered prostate cancer care, announced today that the Centers for Medicare & Medicaid Services (CMS) has assigned a national payment rate for its prostate cancer…
Continue Reading
Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which it will use to grow its business, the company announced Tuesday.
Nashville, Tennessee-based Thyme Care, founded in 2020, partners…
Continue Reading
What You Should Know:
– Thyme Care, a leading value-based cancer care enabler raises $95M in funding capital led by Concord Health Partners, with participation from existing investors including CVS Health® Ventures, Town Hall Ventures,…
Continue Reading
What You Should Know:
– COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s community cancer centers.
– Leveraging COTA’s AI-powered curation engine,…
Continue Reading
What You Should Know: – Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally. – With over…
Continue Reading
